Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform.
Hyndman ME, Paproski RJ, Kinnaird A, Fairey A, Marks L, Pavlovich CP, Fletcher SA, Zachoval R, Adamcova V, Stejskal J, Aprikian A, Wallis CJD, Pink D, Vasquez C, Beatty PH, Lewis JD.
Hyndman ME, et al. Among authors: beatty ph.
NPJ Digit Med. 2024 Jun 20;7(1):163. doi: 10.1038/s41746-024-01167-9.
NPJ Digit Med. 2024.
PMID: 38902526
Free PMC article.